摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Methoxy-6-methylcyclohexen | 1260069-98-4

中文名称
——
中文别名
——
英文名称
3-Methoxy-6-methylcyclohexen
英文别名
3-Methoxy-6-methylcyclohexene;3-methoxy-6-methylcyclohexene
3-Methoxy-6-methylcyclohexen化学式
CAS
1260069-98-4
化学式
C8H14O
mdl
——
分子量
126.199
InChiKey
XYYONDUSJXPAAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    3-Methoxy-6-methylcyclohexen正丁基氯化镁 在 copper(I) bromide 作用下, 以 四氢呋喃 为溶剂, 生成 3-Methyl-6-butylcyclohexen
    参考文献:
    名称:
    Normant,J.F. et al., Bulletin de la Societe Chimique de France, 1979, vol. , p. 309 - 314
    摘要:
    DOI:
  • 作为产物:
    描述:
    对甲苯甲醚氢气 作用下, 以 乙醇 为溶剂, 50.0 ℃ 、4.0 MPa 条件下, 反应 18.0h, 以70%的产率得到4-异丙基环己烷羧酸
    参考文献:
    名称:
    Ruthenium nanoparticles supported on multi-walled carbon nanotubes: Highly effective catalytic system for hydrogenation processes
    摘要:
    Immobilization of small and homogeneously dispersed ruthenium nanoparticles stabilized by 4-(3-phenylpropyl)pyridine ligand (RuL) on functionalized multi-walled carbon nanotubes (RuL-MWCNT) have been prepared and characterized by elemental analysis and transmission electronic microscopy. A comparative hydrogenation study of unsaturated substrates using non-supported (RuL) and supported catalytic systems (RuL-MWCNT) was carried out. For all the substrates, the activity of the supported catalyst was higher towards the full hydrogenated product than that obtained using the non-supported one. Moreover, the catalytic effect of the support nature was studied using RuL immobilized on silica (RuL-SiO2), alumina (RuL-Al2O3) and activated carbon (RuL-AC). The best activities and selectivities were found for RuL-MWCNT system, maintaining its catalytic behaviour upon recycling. (C) 2010 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.molcata.2010.09.006
点击查看最新优质反应信息

文献信息

  • CYCLOHEXENE-3,6-DIYL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE
    申请人:Sasada Yasuyuki
    公开号:US20130270480A1
    公开(公告)日:2013-10-17
    To provide a compound, when the compound has both a high clearing point and a low crystallization temperature, having a wide temperature range of a liquid crystal phase and also an excellent solubility in other liquid crystal compounds, and further having general physical properties necessary for the compound, namely, stability to heat, light and so forth, a suitable optical anisotropy and a suitable dielectric anisotropy. A compound is represented by formula (1): wherein, for example, Ra and Rb are alkyl having 1 to 10 carbons; A 1 , A 2 , A 3 and A 4 are 1,4-phenylene; Z 1 , Z 2 , Z 3 and Z 4 are a single bond or alkylene having 1 to 4 carbons; and m, n, q and r are independently 0, 1, or 2, and a sum of m, n, q and r is 1, 2, 3 or 4.
    为了提供一种化合物,该化合物具有高的清除点和低的结晶温度,具有广泛的液晶相温度范围,同时在其他液晶化合物中具有优异的溶解性,并且进一步具有化合物所必需的一般物理性质,即耐热性、耐光性等,适当的光学各向异性和适当的介电各向异性。该化合物由式(1)表示:其中,例如,Ra和Rb是具有1至10个碳的烷基;A1、A2、A3和A4是1,4-苯撑基;Z1、Z2、Z3和Z4是单键或具有1至4个碳的烷基;m、n、q和r独立地为0、1或2,并且m、n、q和r的总和为1、2、3或4。
  • EMISSIVE COMPOUNDS FOR LIGHT EMITTING DEVICES
    申请人:Zheng Shijun
    公开号:US20160126478A1
    公开(公告)日:2016-05-05
    Disclosed herein are compounds represented by Formula (1), wherein R 2 is an cyano, aryl and/or heteroaryl which can be from an optionally substituted phenyl, optionally substituted pyridinyl and optionally substituted pyrimidinyl; and wherein, R 3 is a heteroaryl which can be from an optionally substituted carbazolyl, an optionally substituted benzocarbazolyl, an optionally substituted phenoxazolyl, an optionally substituted phenothiazenyl and an optionally substituted phenazinyl. Other embodiments provide an organic light-emitting diode device comprising a compound of Formula (1).
    本文揭示了由式(1)表示的化合物,其中R2是氰基、芳基和/或杂芳基,可以来自于可选取代的苯基、可选取代的吡啶基和可选取代的嘧啶基;而且,R3是杂芳基,可以来自于可选取代的咔唑基、可选取代的苯并咔唑基、可选取代的苯并噁唑基、可选取代的苯并噻唑基和可选取代的苯并吩嗪基。其他实施例提供了一种由式(1)的化合物构成的有机发光二极管器件。
  • RESIN COMPOSITION FOR OPTICAL THREE-DIMENSIONAL MODELING
    申请人:Cmet Inc.
    公开号:EP3006484A1
    公开(公告)日:2016-04-13
    To provide a resin composition for optical three-dimensional modeling which gives a three-dimensional object that has high impact strength, is less apt to break, has excellent toughness, has not yellowed, has a high light transmission, and is excellent in terms of color tone and transparency. The resin composition for optical three-dimensional modeling comprises a radically polymerizable organic compound (A), a cationically polymerizable organic compound (B), a radical polymerization initiator (C), and a cationic polymerization initiator (D), and a poly(alkylene glycol) mono(meth)acrylate (A-1) as a part of the radically polymerizable organic compound (A), and an oxetane compound (B-1) as a part of the cationically polymerizable organic compound (B).
    提供一种用于光学三维建模的树脂组合物,该组合物可生成具有高冲击强度、不易破裂、韧性极佳、不黄变、透光率高以及色调和透明度极佳的三维物体。用于光学三维建模的树脂组合物包括可径向聚合的有机化合物(A)、可阳离子聚合的有机化合物(B)、径向聚合引发剂(C)和阳离子聚合引发剂(D),以及作为可径向聚合的有机化合物(A)的一部分的聚(烷基乙二醇)单(甲基)丙烯酸酯(A-1)和作为可阳离子聚合的有机化合物(B)的一部分的氧杂环丁烷化合物(B-1)。
  • CYCLOPROPENIMINE CATALYST COMPOSITIONS AND PROCESSES
    申请人:THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    公开号:US20140288323A1
    公开(公告)日:2014-09-25
    The present invention provides, inter alia, a cyclopropenimine Brønsted base catalyst and a cyclopropenimine scaffold for use as a Brønsted base catalyst. This cyclopropenimine has the structure (100). Methods for making such a cyclopropenimine are also provided. Further provided are processes for carrying out an organic synthetic reaction and processes for catalyzing a proton transfer reaction enantioselectively using such a cyclopropenimine Brønsted base catalyst.
  • COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY
    申请人:CASE WESTERN RESERVE UNIVERSITY
    公开号:US20170165241A1
    公开(公告)日:2017-06-15
    Compounds and methods of modulating 15-PGDH activity, modulating tissue prostaglandin levels, treating disease, diseases disorders, or conditions in which it is desired to modulate 15-PGDH activity and/or prostaglandin levels include 15-PGDH inhibitors and 15-PGDH activators described herein.
查看更多